Salmon retired from Medtronic in September after a more than 20-year tenure at the medtech giant. Most recently, Salmon ...

Datasea (Nasdaq:DTSS) announced progress on R&D efforts related to its brain-computer interface (BCI) technologies.

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

Johnson & Johnson MedTech will be one of several companies set to benefit from a new CMS decision related to pulsed field ...

Intuitive announced that the FDA cleared its da Vinci single port (SP) surgical robot for use in new types of procedures.

Neurovalens announced that it received FDA de novo approval for Modius Lean, its non-invasive neurotechnology for weight ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

Brain-computer interface (BCI) company Science Corp. announced that it appointed Darius Shahida as its new chief strategy ...

GE HealthCare (Nasdaq: GEHC) has sent affected customers a letter recommending updated instructions for certain anesthesia ...

Impulse Dynamics announced today that it raised more than $158 million in financing to support its heart failure treatment ...

Boston Scientific announced today that Health Care Service Corporation (HCSC) now covers its Intracept procedure.